Introduction
The Westernization of dietary patterns in China may lead to the excessive intake of fats and accumulation of lipids in the body which can cause nonalcoholic fat liver disease (NAFLD), diabetes, obesity, cardiovascular disease, atherosclerosis, etc. [1, 2] In addition to the physical activities, the dietary habit is more critical way to be adjusted. NAFLD, characteristic of hepatic lipid accumulation, results from an imbalance between lipid synthesis, DOI: 10.1002/mnfr.201700737 storage, oxidation, and/or secretion, and eventually triggers hepatitis hepatocirrhosis and even hepatoma. [3] Lipids such as triglyceride (TG) and cholesterol (TC) are stored in the form of lipid droplets (LDs) in hepatocytes. Lipids are synthesized in the ER together with the folding of membrane proteins and secretory proteins. An overload of unfolded or misfolded proteins may result in excessive fatty acids retention in the ER followed by the ER stress (ERS), which in turn aggravates the lipid accumulation. Long-term lipid accumulation in the nonadipose cells, i.e., hepatocytes, could exceed the capacity of the cells to manage lipids and cause further chronic ERS and lipotoxicity. [4] MUFAs have the ability to attenuate acute ERS induced by palmitate, while excess fatty acid exposure over long periods of time can exceed the capacity, especially of nonadipose cells. For example, short-term treatment of cells with oleic acid increases very-LDL and TG secretion, whereas prolonged incubation of cells with oleic acid can lead to ERS and suppression of very-LDL secretion. [5] When ERS occurs, the ER initiates the unfolded protein response through the actions of canonical sensors inositolrequiring enzyme-1 (IRE1), protein kinase-like ER kinase (PERK), and ATF6 to restore ER homeostasis. The excessive accumulation of unfolded or misfolded proteins stimulates the ERS sensors to uncouple from GRP78. [6, 7] Among these sensors, IRE1
www.advancedsciencenews.com www.mnf-journal.com is a ribonuclease that splices uXBP1 (X-Box Binding Protein 1) transcripts into the active sXBP1. Then sXBP1 is translocated into the nucleus to promote the transcription of lipogenic enzymes such as acetyl-CoA carboxylase 1 (ACC1) and stearoyl-CoA desaturase 1 (SCD1). [8] In addition, PERK regulates fatty acid synthase (FAS) via sterol regulatory element binding protein-1c (SREBP1c). [9] In the past few decades, plant-derived bioactives have been demonstrated to have the potential to prevent lipid-associated disorders. An epidemiological study involving 1938 healthy adults showed that intake of adequate phytochemicals was beneficial, lowering body weight and body fat. [10] Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, especially in broccoli, was reported to regulate a number of metabolic enzymes including phase I & phase II metabolic enzymes, and lipid metabolism-related enzymes/proteins. [11] Oral administration of the sulfur-radish extract and sulforaphane after carbon tetrachloride (CCl 4 )-induced liver injury decreased the serum level of alanine aminotransferase (ALT), reduced the necrotic zones, inhibited lipid peroxidation, and induced phase 2 enzymes without affecting cytochrome P450-2E1 (CYP2E1). [12] Moreover, longterm consumption of whole broccoli counters NAFLD development enhanced by a western diet as well as hepatic tumorigenesis induced by DEN in male B6C3F1 mice. [13] Therefore, we further hypothesized that SFN presents a preventive effect on the abnormal lipid metabolism via ERS mechanisms. In the present study, high-lipid-induced abnormal lipid metabolism models were established both in vitro and in vivo to explore the protective effects of SFN and focusing on the ER-dependent/independent mechanisms.
Experimental Section

Reagent and Preparation
Sulforaphane (1-isothiocyanato-4-(methylsulfinyl) butane, SFN, purity ࣙ 98%), purchased from LKT laboratories (St. Paul, MN), stock solution (100 mmol L -1 ) was prepared in dimethyl sulfoxide and stored at -20°C. 4-Phenyl butyric acid (4-PBA) was purchased from Sigma-Aldrich (St. Louis, USA). Antibodies against sterol regulatory element binding protein-1c (SREBP1c), XBP1, lamin B were from Proteintech Biotechnologies (USA). Antibody against PERK was from Santa Cruz Biotechnology (USA). TRIZOL reagent kit, TransScript One-Step gDNA Removal and cDNA Synthesis SuperMix kit, and TransStart Top Green qPCR SuperMix kit were purchased from TransGen Biotech (China). Kits for measuring TGs and TC were purchased from Nanjing Jiancheng Biotechnologies (China). The animal chow was purchased from Keaoxieli Feed Co., Ltd (Beijing, China). Polyene phosphatidylcholine (PPC) was purchased from Pharmacy (China) and dissolved in soyabean oil.
Oleic acid and palmitic acid were bought from Sigma-Aldrich (St. Louis, USA). Palmitic acid was prepared as described previously. [14] Briefly, palmitate and oleate were dissolved in 0.1 mol L -1 NaOH at 70°C and filtered respectively to prepare 100 mmol L -1 palmitate stocks and 100 mmol L -1 oleate stocks. Five percent (w/v) free fatty acid (FFA)-free BSA (Sigma) solution was 
Cell Culture and Treatment
Immortalized human hepatocytes (defined as HHL-5) were kindly supplied by Professor Arvind Petal, Medical Research Council Virology Unit, UK. HHL-5 hepatocytes were cultured in DMEM/F12 (1:1) medium with 10% fetal bovine serum, at 37°C, and 5% carbon dioxide. After reaching 70% confluence, cells were pretreated with SFN once (1, 5, 10, 20 μmol L -1 ) for 24 h, followed by 0.25 mmol L -1 fatty acids (FAs; oleic acid: palmitic acid, 2:1) for 5 days.
Establishment of NAFLD Animal Model and Treatments
All the procedures were conducted in conformity with the guidelines of the Institutional Animal Care Use Committee, Heilongjiang province, China. The protocols were approved by the Ethics Committee of Experimental Animals (qualified number: SCXK-Hei-2012-023) at Heilongjiang University of Chinese Medicine.
Male Wistar rats (weighing 160-200 g, 4-6 weeks), specified as pathogen free, were obtained from The Center of Safety and Evaluation of Drugs, Heilongjiang University of Chinese Medicine. Animals were divided into six groups (n = 10) and housed in a controlled environment (temperature 22 ± 2°C and humidity 55 ± 5% with 12/12 h light and dark cycle) with free access to food and water. The formula of the diet is shown in Table 1 .
NAFLD models were established using a high-fat diet (HFD) for 10 weeks. Rats in the control group were given normal diet. The HFD contained 24% fat, 24% protein, and 41% carbohydrate (a percentage of total kcal, according to D12451; www.advancedsciencenews.com www.mnf-journal.com Figure 1 . Model development and treatment. Wistar rats were divided into six groups. Except for rats in the negative control, the other rats were fed with HFD at the beginning of the experiment for 10 weeks. And SFN (5, 10, 20 mg kg -1 ) was orally administrated every 2 days from the first week to the tenth week. PPC, the clinical drug used for the therapy of NAFLD, was implied as the positive treatment group by oral gavage every 2 days from the second day in the first week to the tenth week.
Research Diets Inc.) while the normal chow consisted of 7% fat, 24% protein, and 64% carbohydrate (according to D10012G; Research Diets Inc). Six groups were classified in the animal experiments, and the details of treatments of each group are summarized in Figure 1 . PPC was used as positive group (30 mg kg -1 ), which has been widely applied in clinical study to treat alcohol-induced hepatic fibrosis, hepatocyte steatosis, and nonalcoholic steato-hepatitis. Three doses of SFN (5, 10, and 20 mg kg -1 ) or PPC (30 mg kg -1 ) was orally gavaged to rats three times a week along with the HFD diet. The animal experimental scheme is briefly shown in Figure 1 .
Measurement of Lipid Contents
To determine the TG and TC levels, blood samples were collected from abdominal aorta and centrifuged at 3000 × g for 15 min to obtain serum; liver samples were washed with PBS and lipids were extracted by homogenizing before spinning down. Cultured cells were washed twice with cold PBS and collected. Cellular lipids were extracted by homogenizing. After centrifugation, the supernatants were stored at -80°C before use. The TG and TC levels were measured using TG and TC kit (Nanjing, China) following the manufacturer's instructions and denoted as micrograms of lipid per milligram of cellular protein.
Oil Red O staining for LDs
Intracellular neutral lipid deposition was stained by Oil-red O. In brief, cultured hepatocytes were washed with ice-cold PBS twice, fixed with 4% paraformaldehyde at 4°C for 1 h, and stained with 0.2% Oil-red O in isopropanol for 10 min. The cells were then washed with 60% isopropanol and followed by visualization under the light microscope.
Pathological Examination of liver
Liver sections were fixed in 4% paraformaldehyde solution for 24 h and sent to the Department of Pathology, Heilongjiang University of Chinese Medicine for slide preparation and hematoxylin-eosin staining. The slides were reviewed in a blinded fashion by three pathologists from Heilongjiang University of Chinese Medicine, and were assigned an average histological score. [15] A slight modification was made to this scoring system: scores were multiplied by the percentage of the total area affected, and it was found to be 0.5 if the ratio was less than 5%. Photographs were analyzed using Image J software to determine the number of LDs.
The ER Structure Examined by Transmission Electron Microscope
Transmission electron microscopy was performed. [16] Briefly, samples were fixed with 3% glutaraldehyde, post-fixed in osmium tetroxide, dehydrated with a graded acetone series, and finally embedded in Epon. Ultra-thin sections were stained with uranyl acetate and lead citrate, and examined in a JEM 1220 transmission electron microscope operated at 80 kV. Free-hand selection was used to calculate the perimeter of ER from an average of three images in each experimental group (from three different animals per group) through Image J software according to Hotamisligil's method and all data were collected as mean ± SEM, *p < 0.05. [17] 
Total RNA Extraction and Real-Time PCR analysis
Total RNA was extracted using a TRIZOL reagent kit (TransGen Biotech, China) and quantified by measuring optical density at 260 and 280 nm. cDNA was synthesized by a Transcript One-
Step gDNA Removal and cDNA Synthesis SuperMix kit (TransGen Biotech, China) according to the manufacturer's protocol. The first strand obtained was quantified by real-time quantitative PCR using a Passive Reference Dye I (50×) assay on an ABI Prism 7300 System (Applied Biosystems, CA). The PCR cycle conditions were 94°C for 31 s, then 40 cycles at 94°C for 5 s and 60°C for 30 s. PCR primers for liver tissue and human hepatocytes are shown in Table 2 and Table 3 . [8, 18, 19] 
Extraction of Nuclear Protein and Western Blot Analysis
Nuclear proteins from cells and total proteins from animal liver were extracted using Protein Ext Mammalian Nuclear kit and Cytoplasmic Protein Extraction Kit (TransGen Biotech, China), respectively. Equal amounts of protein (40-60 μg) were separated on 5-10% SDS−PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA). The membrane was blocked with 5% nonfat milk for 30 min at room temperature and then incubated with primary antibody (at 4°C overnight), and followed by the secondary antibody labeled with alkaline phosphatase (at room temperature for 30 min). The membrane was then incubated with the secondary alkaline phosphatase-conjugated IgG and detected with Western Blue www.advancedsciencenews.com www.mnf-journal.com Table 2 . PCR primers for rat liver tissue. antisense 5 -GCCAGAGCAGTAATCTCCTTCT-3 Table 3 . PCR primers for human hepatocytes. Stabilized Substrate for alkaline phosphatase (Promega). The relative densities of the individual bands were analyzed by densitometry using the ChemiImager 4000 (Alpha Innotech, USA).
Statistical Analysis
Results were expressed as mean ± SEM. SPSS 19.0 software was used for statistical analysis. Statistical significance of difference was determined using one way analysis of variance followed by multiple comparisons with a Tukey's test. *p < 0.05 was considered to be significant.
Results
SFN Attenuated TG and TC Accumulation Both In Vitro and In Vivo
To verify whether SFN could improve the lipid accumulation, an NAFLD animal model was established in rats, and TG and TC contents in serum were measured. As shown in Figure 2A , SFN decreased the content of TG and TC in a dose-dependent way. The levels of TG (1.2 mmol L -1 ) and TC (2.6 mmol L -1 ) were reduced to 0.71 and 1.9 mmol L -1 , respectively by SFN (20 mg kg -1 ). Meanwhile, the content of TG and TC in liver presented the similar trend ( Figure 2B ). Pathological examination of livers revealed that many more LDs, characterized as white round vacuoles, accumulated in HFD-rats ( Figure 2C, arrow indicated) . SFN (5-20 mg kg -1 ) and PPC (30 mg kg -1 ) treatments lessened the lipid accumulation seen as white LDs and histological steatosis is represented by the histological score in Figure 2D .
To explore its underlying mechanisms, a cellular model of abnormal lipid metabolism induced by FA was developed in immortalized human hepatocytes HHL-5. FA-induced LDs, stained with oil red O, were examined under light microscopy ( Figure 2E , FA group, arrow position). In contrast to treatment with FA alone, HHL-5 cells incubated with SFN (10 μmol L -1 ) had fewer lighter stained areas ( Figure 2E , SFN + FA group) suggesting that SFN disturbs the formation and distribution of LDs. The intracellular TG and TC contents were significantly reduced by treatment with SFN ( Figure 2F ).
SFN Decreases the Lipogenic Enzymes via Activating the Transcription Factor-SREBP1c and XBP1
In general, the synthesis of TG and TC in liver is controlled by a series of endogenous lipogenic enzymes such as ACC1, FAS, and SCD1. HFD increased the expressions of ACC1, FAS, and SCD1 mRNA by nearly twofold in comparison to normal diet group (Figure 3A) . High doses of SFN downregulated the expressions of these enzymes as effectively as PPC, an efficient lipid-lowering drug ( Figure 3A) . The inhibitory effects of SFN on ACC1, FAS, and SCD1 mRNA expressions were also confirmed in FA-treated HHL-5 cells ( Figure 3B ).
Moreover, a transcription factor-SREBP1c, responsible for the transcription of lipogenesis-related enzymes, was further determined both in FA-induced HHL-5 cells and NAFLD rats. SFN treatment attenuated the expressions of SREBP1c mRNA (Figure 3C ) and SREBP1c protein in rat liver ( Figure 3D ) with comparable effects to PPC treatment. Similarly, in the FAs-induced cell model, SFN (10 and 20 μmol L -1 ) lowered the expression of SREBP1c ( Figure 3E, F) .
To illustrate the role of specific transcription factor XBP1 in ERS pathway, XBP1 was examined both in FA-induced HHL-5 cells and NAFLD rats. SFN attenuated the expressions of XBP1 mRNA ( Figure 3G ) and XBP1 protein ( Figure 3H) , with comparable effects to PPC treatment. Similarly, in the FA-induced cell model, SFN downregulated the XBP1 expression ( Figure 3I, J) .
SFN Protected the Structure of ER and Attenuated LDs Formation
As the key organelle for lipid synthesis, excess lipid accumulation contributes to the morphological aberrance of the ER. HFD accelerates the excessive LDs formation (gray round areas) and accumulation in hepatocytes (Figure 4) . However, SFN treatment, to some extent, appeared to reduce the LDs accumulation with www.advancedsciencenews.com www.mnf-journal.com less grey areas ( Figure 4A ). High doses of SFN diminished the LD accumulation as with PPC group. Under physiological conditions, ER is arranged as slim bundle. However, HFD increased the space between rough ERs and induced ER swelling which was exhibited by the longer perimeter of the ER than that following SFN treatment. SFN shortened the distance between the ERs, and the particles on the ER were clearly visualized, which implied that SFN can protect the ER.
To further quantify the structural changes of the ER during NAFLD, the perimeter of the ER was calculated by the free-hand tools using ImageJ software. HFD lengthened the perimeter of the ER, indicating ER swelling ( Figure 4B ). SFN in turn decreased the perimeter of the ER (90-160 μm) suggesting the protection of the ER by SFN. In order to illustrate the role of PERK in the ERS pathway, PERK was examined in both FA-induced HHL-5 cells and NAFLD rats. SFN attenuated the expressions of PERK mRNA (Supporting Information Figure  S1A ) and PERK protein (Supporting Information Figure S1B ) especially in the high dose group with effects comparable to PPC treatment. Similarly, in the FAs-induced cell model, SFN (10 and 20 μmol L -1 ) downregulated the PERK expression (Supporting Information Figure S1C, D) .
SFN Prevented the Formation of LDs in an XBP1-Dependent Way
To clarify the key roles of XBP1and SREBP1 during the formation of LDs, a series of dynamic and continuous experiments in HHL-5 cells were performed. After pretreatment with SFN (10 μmol L -1 ) for 24 h, HHL-5 cells were exposed to FA (250 μmol L -1 ) for 0, 12, 24 h, 3, and 5 days, respectively and then harvested for determination. TG content rose slowly after incubation with FAs for 24 h and at this time, no visible LDs were found ( Figure 5A) . After 3 days, TG content increased significantly with red LDs visible in the cytoplasm ( Figure 5B ). However, preprotection with SFN significantly decreased the concentration of TG in comparison to FA treatment alone. After 5 days, the red LDs could be more clearly visualized in the FA-treated group. However, the color of red LDs was much lighter and the number of LDs also appeared to decrease after exposure to SFN.
The LD formation and TG synthesis rose in time-dependent manner together with XBP1 mRNA expression. After exposure to FAs for 24 h, XBP1 mRNA expression rose linearly until to the 5th day ( Figure 5C ). SREBP1 mRNA expression rose linearly after exposure to FAs for 12 h until to the 3rd day. However, SFN (10 μmol L -1 ) reduced both XBP1 and SREBP1 mRNA after 24 h ( Figure 5C, D) . Normal rough ER appears as bundle and with ribosome attached on it, but fatty acids lead to ER swelling and SFN improved this situation. SFN also decreased the number of LDs ( Figure 5E ).
To illustrate the roles of ERS in the development of LDs and to clarify if the down regulations of XBP1 and SREBP1 mRNA by SFN were both linked with the ERS, 4-PBA, the specific inhibitor of ERS, was used. [20] 4-PBA is supposed to interact with hydrophobic domains of misfolding proteins and thus prevents their aggregation, which give the chances for correct folding proteins. The number of red LDs stained by Oil-Red was increased in the FA-treated group, whereas 4-PBA reduced the number of LDs with light red ( Figure 5E ). SFN also had a similar effect on the number of LDs ( Figure 5F ). Additionally, the TG content was decreased in the 4-PBA group compared to the FA-treated group, which suggested that 4-PBA could reduce lipid synthesis ( Figure 5G ). Both 4-PBA and SFN treatments attenuated the expressions of XBP1 mRNA ( Figure 5H ). However, unexpectedly, 4-PBA, unlike SFN, could not block the increased-expression of SREBP1 mRNA by FAs ( Figure 5I ). www.advancedsciencenews.com www.mnf-journal.com 
Discussion
The current study has shown that SFN exhibits a protective effect on abnormal lipid metabolism both in vitro and in vivo. SFN protected the structure of the ER when stressed by excessive lipid accumulation and inhibited the expressions of key lipogenic enzymes including ACC, SCD1, and FAS. Moreover, XBP1 and SREBP, two ERS-associated transcriptional factors, were involved in this process.
HFD was identified as an activator of ERS in liver. Recently, ERS response was identified as a crucial mechanism in a variety of liver disorders including NAFLD. [21] Thapsigargin and tunicamycin, the two pharmacologic ERS inducers, lead to hepatic lipid accumulation in mice. [22] Moreover, thapsigargin can activate SREBP-1c followed by an increase in hepatic lipogenesis. [23] In accordance with this, induction of PERK-peIF2α branch in response to ERS enhances lipid accumulation through SREBP-1c activation in hepatocytes. [24] Conversely, these results showed that SREBP1c expression was not controlled by the ERS. Moreover, the ERS was not a major/significant factor in the downregulation of SREBP1c by SFN. SREBP-1c is one of the transcription factors controlling the hepatic lipid metabolism through the regulation of the expression of critical enzymes involved in glycolytic and lipogenic pathways such as FAS, HMG-CoA synthase, and HMG-CoA reductase. [25] It should be noted that SREBP-1c also responds to insulin signal and is essential for glucose carbon utilization and storage. Consequently, it is important to understand whether the activation of SREBP-1c contributes to the insulin signal which is sensitive to the HFD. The level of insulin in serum was measured and showed that SFN has a potential to stimulate insulin (data not shown). It is thus speculated that inhibitory expression of SREBP-1c may be largely associated with insulin secretion after SFN treatment. [26] In contrast, XBP1 is newly identified as a transcription factor governing hepatic lipogenesis. [27] XBP1 is a key regulator of the mammalian unfolded protein response or ERS response. [28] Upon ERS, the proximal sensor and endoribonuclease IRE1α induces unconventional splicing of XBP1 mRNA to generate a mature mRNA encoding an active transcription factor, XBP1s, which directly binds to the promoter region of ER chaperone genes. [29] [30] [31] XBP1 deficiency weakened de novo hepatic lipid synthesis which lead to the concomitant decreases in serum TG, Figure 4 . SFN protected the ER stressed by excessive lipid. Three doses of SFN (5, 10, and 20 mg kg -1 ) and PPC (30 mg kg -1 ) were orally gavaged to rats three times a week along with HFD diet. A) Organelles structure examined by transmission electron microscopy (10 000× and 20 000×). White, square area is pointed to the ER and grey, round areas are LDs. B) ER perimeter was measured by free-hand tools (20 000×). ER perimeter was calculated by Image J software with the free-hand tools and the length was measured from average of three images in each experimental group (from three different animals per group) according to Hotamisligil's method and all data are mean ± SEM, *p < 0.05. www.advancedsciencenews.com www.mnf-journal.com TC, and free fatty acids without causing hepatic steatosis. [27] In this study, XBP1 expression are accompanied with the dynamic processes of LD formation which implied its key role in regulating the TG synthesis. Critical lipogenic genes regulated by XBP1 include SCD1, diacyl glycerol acetyltransferase 2 (DGAT2), and acetyl CoA carboxylase. [32] [33] [34] It should be noted that XBP1 regulates the expression of a subset of lipogenic genes in an SREBP-independent manner. As a result, the inhibitory expression of ACC1 and SCD1 by SFN may be mainly mediated by XBP1. Moreover, other animal studies also suggest that SFN regulates lipid metabolism via the 5 -AMP-activated protein kinase (AMPK) signaling pathway and ACC1. [35] These studies do suggest that dietary broccoli may alter lipogenesis pathways, consistent with our observation.
Conclusion
SFN improved the abnormal metabolism of lipid both in vivo and in vitro through targeting the ERS response pathways. SFN suppressed the lipid accumulation in two distinguished manners involving both ERS-dependent XBP1/ACC and SCD1-and ERSindependent SREBP1/FAS pathways. 
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